Sofinnova Investments, Inc. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 118 filers reported holding TG THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$3,406,000
-49.2%
65,474
-73.9%
0.20%
-59.2%
Q3 2020$6,700,000
-50.6%
250,401
-64.0%
0.50%
-41.9%
Q2 2020$13,566,000
+400.8%
696,390
+153.0%
0.86%
+240.6%
Q1 2020$2,709,000
-69.9%
275,305
-66.1%
0.25%
-61.3%
Q4 2019$9,006,000
-7.5%
811,292
-53.2%
0.65%
-26.2%
Q3 2019$9,734,000
-10.8%
1,733,628
+37.4%
0.88%
-12.3%
Q2 2019$10,911,000
+285.7%
1,261,384
+258.5%
1.00%
+267.4%
Q1 2019$2,829,000351,8110.27%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
RA Capital Management 6,880,323$38,633,0002.30%
Eversept Partners, LP 773,501$4,343,2081.35%
Opaleye Management Inc. 612,500$3,439,0001.24%
BRIDGER MANAGEMENT, LLC 2,334,196$13,107,0001.08%
Sofinnova Investments, Inc. 1,733,628$9,734,0000.88%
PURA VIDA INVESTMENTS, LLC 354,719$1,992,0000.34%
683 Capital Management, LLC 400,000$2,246,0000.25%
NEXPOINT ASSET MANAGEMENT, L.P. 649,460$3,646,0000.23%
Artal Group S.A. 900,000$5,054,0000.20%
Frontier Wealth Management LLC 226,750$1,273,0000.19%
View complete list of TG THERAPEUTICS INC shareholders